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Abstract 
The degradation of organic micropollutants in wastewater treatment is suspected to 
depend on co-degradation i.e. be dependent on concentrations of substrate. This 
complicates predicting and modelling their fate. The effect of humic acid, as a model for 
complex organic substrate, was investigated in relation to the biodegradation of 
pharmaceuticals by suspended biofilm carriers adapted to polishing effluent water from 
a tertiary sewage treatment plant. Twelve out of 22 investigated pharmaceuticals were 
significantly biodegradable. The biodegradation rate constants of ten of those 
compounds were increasing with increased humic acid concentrations. At the highest 
humic acid concentration (30 mgC/L), the biodegradation rate constants were four times 
higher than the biodegradation rate constants without added humic acid. This shows that 
the presence of complex substrate stimulates degradation via a co-metabolism-like 
mechanism and competitive inhibition does not occur. Increases of rate constant per 
mgC/L are tentatively calculated.  
 
Keywords: Moving bed biofilm reactor, co-metabolism, biodegradation, dissolved 
organic carbon, humic acid 
1. Introduction 
Effluents from municipal wastewater treatment plants (WWTPs) contain 
pharmaceuticals (typically µg/L), as many of these compounds are not removed in 
traditional wastewater treatment processes (Falås et al., 2012a; Wang et al., 2015). As 
pharmaceuticals are designed to have biological effects, it is inevitable that they can 
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potentially have effects on aquatic life, and thus regulation authorities increasingly 
develop water quality criteria for pharmaceuticals in the ng/L and µg/L ranges, which is 
not achievable with currently used wastewater treatment methods (Álvarez-Muñoz et al., 
2015). Therefore, there is of increasing interest to understand the mechanisms of the 
removal of pharmaceuticals in the wastewater treatment processes and identify 
technologies that can achieve better removal. 
Besides chemical methods for polishing pharmaceuticals in wastewater effluents such 
as ozonation (Hansen et al., 2016), biofilm methods are being investigated as methods 
to improve removal of pharmaceuticals from wastewater (Escolà Casas et al., 2015; 
Falås et al., 2013, 2012b; Joss et al., 2004). The moving bed biofilm reactor (MBBR) 
consists of a wastewater reactor containing suspended plastic carriers that serve as 
support to biofilm growth, making it possible to utilise the whole tank volume for 
biomass growth (Ødegaard, 2006). Over the past decades, MBBR have been used 
successfully to treat different types of wastewater containing organic chemicals of 
concern  (Borghei and Hosseini, 2004; Chen et al., 2007; Escolà Casas et al., 2015). 
Previous studies have already demonstrated that MBBR reactors achieve similar or 
better biodegradation efficiencies for micropollutants compared to activated sludge 
treatment.(Escolà Casas et al., 2015; Falås et al., 2012b; Mazioti et al., 2015)   
Biomass communities found in wastewater treatment facilities are related to the 
conditions under which they grow (Cydzik-Kwiatkowska and Zielińska, 2016). An 
important parameter for these conditions is the type and concentration of carbon in 
wastewater. However, there is a lack of knowledge on how this parameter affects 
biofilm activity. Biodegradation of micropollutants may interact with organic matter by 
two types of mechanisms: co-metabolism and competitive inhibition. The terms ‘co-
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metabolism’ and ‘competitive inhibition’ will be used in this article as defined below 
because they were found to be the most suitable. It is important to notice that such terms 
do not exactly correspond to their definition in biochemistry. 
Co-metabolism involves the transformation of a non-growth substrate (pharmaceutical) 
in the obligate presence of a substrate that is utilised by the biomass for growth. Non-
growth substrate refers to compounds that are unable to support cell replication at the 
given concentrations (Dalton et al., 1982), such as micropollutants in realistic 
wastewater conditions. Namely, the obligatory presence of a growth substrate or another 
utilisable compound is essential to the main biomass and induces enzymes for 
assimilation or co-factors for biodegradation (Arp et al., 2001). Some relevant studies in 
the literature have found that phenol and glucose act as primary growth substrates and 
enhance the biodegradation of 4-chlorophenol, which is considered a non-growth 
substrate at low concentrations (Tobajas et al., 2012). Essentially under such conditions 
the higher the substrate concentration, the faster the degradation of the pollutant. 
Competitive inhibition proposes that, a pollutant and the usual grow substrate compete 
for active sites (e.g. of enzymes) for being processed. Thus the higher the substrate 
concentration the slower the degradation of the pollutant (Chang and Alvarez-Cohen, 
1995). To minimise and optimise the discrepancy between the observed removal and 
estimated removal of micropollutants, previous studies in the literature demonstrate that 
the ability of the model used to predict micro-pollutant degradation improved after the 
addition of an parameter regarding competitive inhibition (Plósz et al., 2010). 
Experimentally, Joss et al. (2004) found that differences in the removal rates of 
oestrogens, between the batch experiment and the corresponding compartment of full-
scale plants, could be interpreted in terms of the competitive inhibition of oestrogen 
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degradation by the substrate. This was explained because the batch experiments were 
run without adding a primary effluent, while the full-scale plants were operated under 
regular conditions (Joss et al., 2004).   
According to the descriptions above, co-metabolism and competitive inhibition thus 
make opposite predictions on the effect of substrate on pollutant removal. 
The aim of this study was to investigate the effect of additional carbon sources on the 
removal of micropollutants by biofilms. Specifically, laboratory-scale MBBRs were 
used to mimic a potential treatment for effluent wastewater from a CAS treatment plant. 
In this test, humic acid (HA) was chosen to simulate different concentrations of 
complex carbon (i.e. not easily biodegradable carbon) as a carbon source (feed) to 
induce biological activity. This way it was tested whether enhanced carbon loads are 
beneficial or detrimental to degradation of recalcitrant compounds (meaning whether 
the effect of co-metabolism or competitive inhibition by additional carbon is 
predominant).  
2. Methods 
2.1 Chemicals  
The investigated micropollutants include antibiotics (azithromycin, ciprofloxacin, 
sulfadiazine, sulfamethizole, sulfamethoxazole, trimethoprim and the sulfadiazine 
metabolite acetyl-sulfadiazine), beta-blockers (atenolol, metoprolol, propranolol and 
sotalol), antindepressants/antiepileptics (venlafaxine and carbamazepine), analgesics 
(diclofenac, ibuprofen, phenazone and tramadol) and X-ray contrast media (iopromide, 
iohexol and iopamidol). The investigated compounds were obtained from different 
suppliers, as described in the supplementary information (SI; Table S1). Formic acid 
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and gradient-grade methanol were obtained from Merck (Darmstadt, Germany). Humic 
acid sodium salt was purchased from Sigma-Aldrich (Steinheim, Germany), and water 
of a gradient grade came from Sigma-Aldrich (Munich, Germany).  
2.2 Instruments 
The HPLC was equipped with a dual low-pressure mixing ternary gradient system, 
namely Ultimate 3000, from Dionex. This system consisted of a pump, a column oven 
and a degasser, which were all 3000 series, and a 3000 TSL autosampler (WPS 3000 
TSL). The mass spectrometer was an API 4000 (ABSciex, Framingham, MA, USA). 
The HPLC-MS/MS conditions are the same as the supplementary information (S2) in 
Escolà Casas et al. (2015). 
2.3 Wastewater and the growth of biofilm carriers 
The effluent wastewater used for the growth of the biofilm carriers and for the 
experiment was collected from Bjergmarken WWTP in Roskilde, Denmark. 
Bjergmarken WWTP is a classical activated sludge plant, with nitrification and 
denitrification as well as biological phosphorus removal. The wastewater was stored at 
4°C and before starting the experiment it was allowed to reach room temperature. The 
characteristics of the wastewater in this experiment are presented in Table S2.  
To grow the biofilm on the carriers, 150 new MBBR-carriers K5 (800m2/m3 specific 
surface area) from AnoxKaldnesTM (AnoxKaldnes, Lund, Sweden) were incubated in a 
beaker containing 1500 mL of the described effluent wastewater. The carriers were 
stirred with a magnetic stir-bar and the wastewater was fully changed three times a 
week. No additional aeration was performed, as oxygen consumption in the system was 
very low. These conditions were maintained for four months. At that time, the carriers 
were ready for the batch experiment. 
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2.4 Experimental design and procedure 
The experiment consisted in testing the degradation of spiked pharmaceuticals in 
secondary treated wastewater in the presence of three defined concentrations of humic 
acid (all in triplicates). Humic acid sodium salt was used in this experiment, as it is 
easier to solubilise than natural, isolated humic acid. To prepare solutions of humic acid  
4.9, 7.4 or 24.7 mg humic acid sodium salt were added into 200 mL volumetric flasks 
which were filled with effluent from Bjergmarken WWTP.  
For the spiking, 10 μL of a stock solution containing pharmaceuticals in methanol were 
transferred to 100 mL Erlenmeyer flasks. After the methanol had evaporated, 40 mL of 
the previous humic acid sodium salt solutions in effluent water were introduced into the 
respective flasks. This gave initial concentrations of the pharmaceuticals ranging 
between 1.2 and 14.6 µg/L. 
When the flasks were prepared, three carriers with biofilm were placed into each of 
them. This resulted in a filling ratio of 23%, corresponding to 104 m2/m3 surface area, 
which was kept constant (maximum variations of ±3%) by adjusting the number of 
carriers to the remaining water at certain time-points after sampling. The experiment 
was more optimised for gaining comparable and stable results than for working at 
optimal filling ratio. The Erlenmeyer flasks were placed on a mechanical shaker (120 
rpm) for a period of two weeks. The design of the experiment is shown in Table S3. 
2.5 Quantification and analysis  
2.5.1 General parameters 
Dissolved oxygen and pH were measured with a multi-parameter meter (Multi 3420, 
WTW), while dissolved organic carbon (DOC) concentration was analysed by a total 
organic carbon analyser (Shimadzu, TOC-V wp with ASI-V, Japan). COD and other 
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parameters mentioned for wastewater in the effluent from Bjergmarken WWTP (Table 
S2) were measured following Danish Standard Methods (http://www.ds.dk/en, accessed 
June 2015). 
Biomass on the MBBR carriers was determined by using a digital balance (Sartorius 
Basic, BP 210D) and a drying oven (SalvisLab Thermocenter, TC40). To do so, two 
carriers from each flask, and new carriers without biofilm, were placed in an aluminium 
foil cup, dried overnight at 105°C and then weighed. Differences in weight between the 
new carriers and carriers with biofilm coverage were used as the dry biomass content. 
2.5.2 Pharmaceuticals analysis 
For the analysis of pharmaceuticals, for each time-point and flask, 1 mL of water was 
taken with an Eppendorf pipette and directly put into HPLC vials. The samples were 
immediately stored at -20°C. Before analysis they were brought up to room temperature 
and centrifuged for 10 min at 6000 rpm. Afterwards, 900 μL of the supernatant were 
transferred to a new HPLC vial by using a glass syringe. Subsequently, 100 μL of 
internal standard solution (sulfadiazine 13C6; trimethoprim D3; ac-sulfadiazine 13C6; 
ciprofloxacin D8; clindamycin D3; citalopram D6; propanolol D7; (13C1,D3 N-methyl)- 
erythromycin; ibuprofen D3) were added to each sample, using again a glass syringe. 
Finally, 50 μL of the prepared samples were injected and analysed by means of HPLC-
MS/MS.  
2.5.3 Data treatment  
Quantification was done via Analyst 1.6. After quantification, all of the concentrations 
were fitted with single first-order degradation kinetics (Equation 1) by means of 
Graphpad Prism 5.0. In equation 1, C0 is the initial concentration of each 
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pharmaceutical while C is the actual concentration of each pharmaceutical with time. 
One degradation rate constant (k) was assumed to be valid over the entire period. 
kteCC  0                                          (Equation 1) 
3. Results and discussion 
3.1 General parameters 
The initial pH values of the reactors increased slightly in correspondence with 
increasing concentrations of added humic acid sodium salt, which is consistent with the 
fact that salt is alkaline. The pH increased further during the experiment, which could be 
explained by the mineralization of the humic acid that would leave an equivalent 
amount of alkalinity (Table 1).  
The biomass on the carriers was calculated to correspond to 2.5 g of dry matter per litre 
(33 mg/carrier). The quantified biomass was lower in this work than in previous studies, 
which quantified 3.1 to 3.2 g of dry matter per litre ((Escola Casas et al. (2015); Falås et 
al. (2013)), indicating a possible lower bioactivity than in previous studies. A reason for 
that is that the biofilm in the present study was cultured on wastewater treatment plant 
effluent, which contained considerable lower organic matter concentrations than the 
MBBR reactors in literature working on wastewater. Furthermore, the carriers filling 
ratio of this study (23%) was also lower than both values from Escola Casas et al. (2015) 
with 50% and Falås et al. (2013) with 35% which was fine for a mechanistic study such 
as this experiment.  
Measured initial DOCs agreed with nominal concentrations calculated by measuring the 
background DOC in the wastewater and the organic carbon content in the humic acid 
salt (0.32 mgC/mg humic acid). The DOC of the control flask (C) and the flask without 
the addition of humic acid (HA0) increased during the two weeks of the experiment. 
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This could have been a consequence of the sampling procedure, which might have 
added impurities to the samples. On the contrary, the flasks spiked with humic acid 
exhibited decreasing DOC during the experiment, which is most likely because of the 
humic acid mineralisation, as also suggested from the increasing pH. In this case, the 
decrease of DOC due to mineralisation could have over-compensated the increase of 
DOC due to the sampling. Interestingly, the DOC in the flask spiked with the highest 
amount of humic acid was observed to decrease proportionally much more than the 
flasks spiked with lower levels of humic acid. As it might be expected that the 
biodegradable fraction of the humic acid is constant it could be expected that some of it, 
due to the higher concentration and pH, precipitated on the glass or aggregated to 
smaller particles which were not measured in the DOC analysis. 
3.2 Removal of pharmaceuticals 
The removal of pharmaceuticals was assessed by measuring the concentrations of the 
pharmaceuticals during the experiment. To do so, the concentrations of pharmaceuticals 
were plotted vs time. The data were fitted, when possible, to single first-order 
degradation kinetics as explained in Section 2.5.3. The measurements and fittings can 
be seen in Figure 1 for six representative compounds and in Figure S1 in the SI for the 
rest of compounds.  
13 out of 22 compounds were biodegraded by the biofilm. This could be confirmed 
because the control flasks showed much slower removal than the test flasks (mediated 
by biomass suspended in water). Single first-order kinetics could be fitted with R2 
higher than 0.8 for these 13 compounds. The removal rate constants (k from Equation 1) 
for the different additions of humic acid (Figure 2 and Table 2) were used to further 
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investigate the effect of humic acid on the biodegradation of pharmaceuticals (Section 
3.3). It was known that diclofenac was one of the most persistent compounds, and its 
rate constant in this study was also lower than most of the investigated compounds. 
Tran et al. (2009) investigated that the biodegradation of ten pharmaceuticals by an 
enriched nitrifier culture and found poor biodegradation removal of compounds 
containing at least one chlorine group in the molecular structure, such as clofibric acid 
and diclofenac. In this case, the chemical structure may hinder biotransformation 
processes.  
The biofilm on the carriers was not able to degrade 9 out of 22. Some compounds 
presented no significant removal in both, controls and test flasks (phenanzone, 
sulfadiazine, sulfamethoxazole, tramadol and venlafaxine) (Figure S1). This indicated 
that those compounds were not degradable under the test conditions (test flasks). Other 
compounds showed removal rates that were significant but not statistically different 
from the control (azithromycin, clarithromycin, erythromycin, roxithromycin). For these 
compounds degradation in the control reactor was detected. This might be due to either 
biodegradation by bacteria present in the effluent wastewater in suspension or abiotic 
reactions. Furthermore, hydrolysis or photolysis might lead to slightly reduce the 
concentrations of pharmaceuticals as well. In this case, even if the compounds were 
degradable in the test conditions, it was thus not possible to distinguish between the 
removal by suspended bacteria and the removal mediated by the biofilm. Therefore the 
effect of the humic acid addition was not assessed for these nine compounds.  
In order to make the results comparable with other studies in the literature, the removal 
rate constants (k) were normalized to the biomass content of the carriers (kbio [h-1·L·g-1]). 
Compared to previous investigations on the degradation of pharmaceuticals by MBBR, 
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the kbio values in this work are ten to hundred times lower (Table S4) than those 
described for the same pharmaceuticals by Escolà Casas et al. (2015) and Falås et al. 
(2013). An explanation for this might be that the biofilm investigated in this study was 
grown as polishing reactor in effluent wastewater and it was thus acclimatised to lower 
C loads. Therefore, the biofilm was probably adapted to slow metabolism as an 
adaptation to the low-nutrient environment. 
3.3 Influence of humic acid on pharmaceutical degradation  
Considering the removal rate constants of the 13 pharmaceuticals which exhibited 
biodegradation, it is clear that increasing the DOC by adding humic acid affected the 
degradation kinetic of pharmaceuticals. To create an overview of the influence of the 
initial DOC on the kinetic of pharmaceutical biodegradation, degradation rate constants 
of the six representative compounds are shown in Figure 2 (all pharmaceuticals are 
shown in Figure S2).  
All the biodegradable pharmaceuticals appeared to degrade faster in test flasks with 
increased humic acid concentration. Regarding the mentioned theories on the interaction 
of organic carbon with biodegradation (Section 1), it thus appears that increased “co-
metabolism” is the main effect of increased humic acid concentration for the studied 
compounds. Competitive inhibition appears not to be relevant for humic acid 
interactions with the biodegradation of pharmaceuticals. Furthermore, based on the low 
COD values of the wastewater (described in Table S2) and  continuous shaking during 
the experiment (dissolved oxygen measured at 8 mg/L), co-metabolic degradation of 
pharmaceuticals occurred. This means that pharmaceuticals were oxidised by an 
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enzyme or co-factor produced during the microbial metabolism of another growth 
substrate with oxygen (Tran et al., 2013).  
3.4 Relationship between total concentration of organic matter and rate constant 
The relation between k and the initial DOCs for the biodegradable pharmaceuticals was 
plotted and it is shown in Figure 3 and Table 2. According to the fittings, the slopes of 
10 out of 13 compounds are positive, which suggest that the addition of humic acid 
stimulates the biodegradation of pharmaceuticals in biofilms. Based on the slope, the 
effect of initial DOC on k could be stated to be stimulated from -0.6% to 26% per 
mgC/L. The average stimulation of for all biodegradable pharmaceuticals was 7.4% per 
mgC/L and the 25%, 50 % and 75% percentiles were 2.8, 6.4 and 8.7 % per mgC/L, 
respectively. As the effect of DOC for half of the biodegradable compounds fall in a 
relatively narrow range we propose that this can be used as a default value in modelling 
the effect of increased DOC in a WWTP in cases there a specific value isn’t known for 
a pharmaceutical. 
As results in Figure 3, the flasks containing the highest level of DOC (initially 30 
mgC/L) gave rate constant double or triple the values obtained for the flasks without 
addition of humic acid (initially 4.4 mgC/L). Taking this into account, it seems that the 
addition of carbon can enhance the efficiency of MBBR reactors. Therefore, further 
studies with more concentration levels should be done to establish precise correlations 
between the levels of DOC and the removal of pharmaceuticals in water. 
4. Conclusion 
Generally, the majority of biodegradable pharmaceuticals degraded faster at higher 
DOC levels. This indicates that co-metabolism may be the most important mechanism 
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when humic acids interact with the degradation of pharmaceuticals. The average stimulation 
of the first-order degradation rate for biodegradable pharmaceuticals was 5% per mg DOC. 30 
mgC/L by humic acid addition enhanced about three times the biodegradation 
performance of the laboratory-scale MBBRs.  
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